None listed
Conditions
Brief summary
The hypothesis (based of the previous literature) of the study that obese patients should receive higher prophylactic anticoagulant doses. Therfore, the purpose of the study was to evaluate drug dosing practice of prophylactic anticoagulants in obese patients who underwent gastric band surgery and to look at the clinical outcomes (venous thromboembolism and major bleed). .
Interventions
No intervention was done. Drug dosing practice of enoxaparin and outcomes (venous thromboembolism and major bleed) were accessed in Laparoscopic adjustable gastric band patients. Patients were followed-up retrospectively from digital medical record for 90 days to observe any venous thromboembolism and major bleed incidence.
There were 2 cases venous thromboembolism identified.
Data was collected from year 2013-2017
Sponsors
Dr Syed Tabish Razi Zaidi
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
A retrospective cohort study was conducted of adult (age greater than or equal to 18 years) obese patients (BMI more than or equal to 30 kg/m2) who underwent primary and revisional bariatric surgery at the Royal Hobart Hospital (RHH) and the Hobart Private Hospital (HPH), from 1 Jan 2013 to 31 Dec 2017
Exclusion criteria
Patients were excluded from the study if they were on regular anticoagulant or vitamin K therapy, underwent a concurrent surgical procedure (e.g. hysterectomy), or had an established congenital or acquired bleeding disorder, varicose veins, renal impairment with an estimated glomerular filtration rate < 60 mL/min/1.73m2, prior heparin-induced thrombocytopaenia, haemorrhagic stroke within the previous 3 months, other surgery within the previous 3 months, or if relevant information was missing.
Outcome results
None listed